Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma

Monoclonal antibodies (mAbs) directed against antigen-specific of multiple myeloma (MM) cells have Fc-dependent immune effector mechanisms, such as complement-dependent cytotoxicity (CDC), antibody-dependent cellular cytotoxicity (ADCC), and antibody-dependent cellular phagocytosis (ADCP), but the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Romano, Alessandra, Storti, Paola, Marchica, Valentina, Scandura, Grazia, Notarfranchi, Laura, Craviotto, Luisa, Di Raimondo, Francesco, Giuliani, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297441/
https://www.ncbi.nlm.nih.gov/pubmed/34307150
http://dx.doi.org/10.3389/fonc.2021.684561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297441/
https://www.ncbi.nlm.nih.gov/pubmed/34307150
http://dx.doi.org/10.3389/fonc.2021.684561

Ejemplares similares